Comparing pathological complete response rate using oral capecitabine versus infusional 5‐fluorouracil with preoperative radiotherapy in rectal cancer treatment

Publisher： John Wiley & Sons Inc

E-ISSN： 1445-2197|88|1-2|62-65

ISSN： 1445-1433

Source： ANZ JOURNAL OF SURGERY, Vol.88, Iss.1-2, 2018-01, pp. : 62-65

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Is the Standardized Uptake Value of FDG-PET/CT Predictive of Pathological Complete Response in Locally Advanced Rectal Cancer Treated with Capecitabine-Based Neoadjuvant Chemoradiation?

By  

Oncology, Vol. 84, Iss. 4, 2013-01 ,pp. : 191-199

Karger

Access to resources Recommend Favorite

Oral fluoropyrimidine versus intravenous 5‐fluorouracil for the treatment of advanced gastric and colorectal cancer: Meta‐analysis

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 33, Iss. 1, 2018-01 ,pp. : 209-225

John Wiley & Sons Inc

Access to resources Recommend Favorite

Infusional 5-Fluorouracil and Mitomycin C: An Effective Regimen in the Treatment of Advanced Gastric Cancer

By  

Oncology Research and Treatment, Vol. 28, Iss. 3, 2005-03 ,pp. : 128-132

Karger

Access to resources Recommend Favorite

Feasibility of Preoperative Chemotherapy with Docetaxel, Cisplatin, and 5-Fluorouracil versus Adriamycin, Cisplatin, and 5-Fluorouracil for Resectable Advanced Esophageal Cancer

By  

Oncology, Vol. 92, Iss. 2, 2016-12 ,pp. : 101-108

Karger

Access to resources Recommend Favorite

Preoperative Treatment Combining Capecitabine with Radiation Therapy in Rectal Cancer: A GERCOR Phase II Study

By  

Oncology, Vol. 73, Iss. 3-4, 2008-04 ,pp. : 169-176

Karger

Access to resources Recommend Favorite